References
Products Transfection
Free Sample Offer
Instruction for Use:
In the „Transfection Reagent Selection Guide“ you can find existing references by setting different filters e.g. for your combination of nucleic acid and cell type. Appropriate keywords in the “Search references“ at the top of the page can also yield a result. A reference indicates that the found transfection reagent has been successfully used for the corresponding application. Ideally, tested transfection parameters and transfection efficiencies are specified.
No reference? > General Selection Guide
If the list does not include a reference concerning your cell type, this does not mean that there is no suitable reagent available, but only that there is no report of experiences with this cell type. In this case it is necessary to preselect (General Selection Guide) and test a reagent (Free Sample Offer). If you want to write an application note for us we will make you an Offer for consideration.
| CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Human primary fibroblasts (derived from ALS patients) | Human | unknown | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | M. Milani et al., J. of Neuroinflammation, 2021, 18: 132, doi.org/10.1186/s12974-021-02184-1 | Link | |||
1BR.3 |
Human primary fibroblasts | Human | unknown | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | I. Abramowicz ez al., HMG Advance Access, 2016 | |||
1BR3hTERT |
Human hTERT immortalized fibroblasts | Human | unknown | cell line | adherent | plasmid | Metafectene PRO | publication | K. M. Zimmerman, PhD Thesis, 2013, University of Sussex | Link | |||
1BRneo |
Human transformed fibroblasts | Human | unknown | cell line | adherent | plasmid | Metafectene PRO | application note |  |
||||
2fTGH |
Human fibrosarcoma cell line | Human | unknown | cell line | plasmid | Metafectene | publication | A. J. Scarzello et al., Mol. Biol. Cell, Jul 2007; 18: 2455 - 2462 | Link | ||||
BON |
pancreatic neuroendocrine tumor cell line | Human | unknown | cell line | siRNA | Metafectene SI | publication | X. Zhang et al., J. Cell Biol., 2017, doi.org/10.1083/jcb.201702099 | Link | ||||
BON |
pancreatic neuroendocrine tumor cell line | Human | unknown | cell line | siRNA | high troughput application | Metafectene SI | publication | X. Zhang et al., J. Cell Biol., 2017, doi.org/10.1083/jcb.201702099 | Link | |||
FLYRD18 |
Human fibrosarcoma retrovirus packaging cell line | Human | unknown | cell line | adherent | plasmid | K2 Transfection System | application note | |
||||
HEp-2 |
Human carcinoma cell line (HeLa contaminant) | ATCC CCL-23 | Human | unknown | cell line | adherent | plasmid | stable transfection | Metafectene | publication | J.-S. Kim et al., Cancer Biol. & Ther., 2012, 13: 1307–1318, doi.org/10.4161/cbt.21788 | Link | |
HEp-2 |
Human carcinoma cell line (HeLa contaminant) | ATCC CCL-23 | Human | unknown | cell line | adherent | plasmid | Metafectene PRO | publication | R. S. Cruz Cosme et al., J. Virol., Apr 2009; 83: 2839 - 2850 | Link | ||
HEp-2 |
Human carcinoma cell line (HeLa contaminant) | ATCC CCL-23 | Human | unknown | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | H. Chi et al., Lin Chuang Er Bi Yan Hou Ke Za Zhi, Nov 2005; 19(21): 992-5 | ||
KB |
Human cancer cell line (Hela contaminant) | ATCC CCL-17 | Human | unknown | cell line | adherent | plasmid | Metafectene | publication | K. Konopka et al., Cell Mol Biol Lett, Jan 2009; 14(1): 70-89 | |||
KMST-6 |
Human immoralized fibroblasts | Human | unknown | cell line | adherent | plasmid | Metafectene PRO | publication | S. Kanyanda, Dissertation, 2012, University of the Western Cape | Link | |||
MRC5VI |
Human fibroblast cell line, SV40 transformed and immortalised | Human | unknown | cell line | adherent | plasmid | Metafectene PRO | publication | S. Sertic et al., PNAS, Aug 2011; 108: 13647 - 13652 | Link | |||
NCI-H290 |
Human pleural malignant mesothelioma cell line | Human | unknown | cell line | plasmid | stable transfection | Metafectene | publication | S. Abe et al., Cancer Sci., 2016, 107: 1198-1205; doi: 10.1111/cas.12985 | Link | |||
NLF |
Human neuroblastoma cell line | Human | unknown | cell line | plasmid | Metafectene | publication | A. S. K.Yerabham et al., PLOSONE, 2018, doi.org/10.1371/journal.pone.0191162 | Link | ||||
NLF |
Human neuroblastoma cell line | Human | unknown | cell line | adherent | plasmid | Metafectene | publication | P. J. Hendriks, Dissertation, 2012, Heinrich-Heine-Universität Düsseldorf | Link | |||
NLF |
Human neuroblastoma cell line | Human | unknown | cell line | plasmid | Metafectene | publication | N. .J. Bradshaw et al., PLoS ONE, 2014, 9 (10): e111196, doi:10.1371/journal.pone.0111196 | Link | ||||
NLF |
Human neuroblastoma cell line | Human | unknown | cell line | plasmid | Metafectene | publication | V. Bader et al., J. of Visualized Experiments, DOI: doi:10.3791/4132 | Link | ||||
NLF |
Human neuroblastoma cell line | Human | unknown | cell line | plasmid | RNA-Interference | Metafectene | publication | S. Vomund et al., Cerebral Cortex,March 2017, 27: 2052-2063 | Link | |||
ORC1-P4hTERT |
Human telomerase (hTERT)-immortalised fibroblast cell line | Human | unknown | cell line | adherent | plasmid | Metafectene PRO | publication | K. M. Zimmerman, PhD Thesis, 2013, University of Sussex | Link | |||
SHEP-SF |
Human neuroblastoma cell line | Human | unknown | cell line | adherent | plasmid | Metafectene | publication | T. Müller et al., Mol. Biol. Cell, Jan 2007; 18: 201 - 210 | Link |
 |
Fax-order |
Feel free to order by fax:
0049 89 32479952
Europe
0049 89 32479952
USA/Canada
01149 89 32479952
Australia
001149 89 32479952
 |
Email-order |
Feel free to order via email: order@biontex.com
 |
Online-order |
To view the correct product and freight prices, please select your region.